Cimatron Ltd, (NASDAQ–CIMT)
Valuation-$7.53
Price August 10, 2007-$2.12

With some trepidation, we are recommending CIMT for purchase. We bought this stock several years ago at about the same price and ending up selling it for about a 50% loss for taxes. It has been a “value-trap” for years.

Q2 results (6/30/2007) showed sales up 9% to $5.5 million, gross margin was up to 85%, and the company made $291,000 or $.04 per share (un-taxed). The stock has traded as high as $4.73 and as low as $1.12 over the last year.

The catalyst, aside from new products that will hopefully continue to drive sales and profits, is that they have exercised an option in early July to purchase a 51% share in their Italian distributor that did over $10 million in sales in 2006. The purchase price is cheap (under $1 million) and the company is supposedly profitable. At a 51% ownership level (previously owned 27.5%), they will have to consolidate Microsystems sales and operations results (less 49% of any profit or loss). Aside from growing fundamentals, this should boost their reported revenues by a substantial percentage beginning in the September quarter (Q3).

Our hope here is that the sales increase will get more attention for Cimatron, and investors will realize how undervalued it is.

With $1.16 a share in cash (55% of the market cap), 85% margins, making money and a publicly announced catalyst that has not been reflected in the stock price, we think this is a good bet.

The daily trading volume has been nearly 35,000 shares.

We think anything under $2.25 is a good price.

CIMT is trading at a measley 28% of our valuation.

About Cimatron
With more than 20,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time. Cimatron’s cutting-edge CAD/CAM solutions are widely used in the automotive, medical, consumer plastics, electronics, and other industries.
Founded in 1982, Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. Cimatron’s subsidiaries and extensive distributor network are located in over 35 countries to serve customers worldwide with complete pre- and post-sales support. For more information, please visit http://www.cimatron.com.

Last week we went 6 up, 8 down and 2 even. Our biggest DOGS are: PARL, LINN.ob, AVSO.ob, BDR, ARIS.ob, ILOG and MEDW. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is -1.0%,+17.0% and +35.0% respectively. Since inception we are now 17 stocks up and 7 down (3 of which are down less than 10%).

We were down 1% this past week and are now up 17.0% so far in 2007. The DOW, NASDAQ and the S+P 500 were all up, with gains ranging from .4% (DOW) to 1.4% (S+P 500) last week, and are all now up from 2.5% (S+P 500) to 6.2% (DOW) for the year.

We are now up more than double the DOW, triple NASDAQ and 7 times the S+P 500 averages in 2007. The Russell 3000 and the Wilshire 5000 are both up about 2.5% for the year.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock (unless we double-up–then it is $20,000), less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Earnings on BDR last week.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.44 to $13.84 last week.
Short Interest was 5.7 million at July 13th.
We got some huge volume last week, almost 2 million shares on 2 days and over 900,000 on Friday. May be some short covering going on that is driving the price and volume. Price got as high as $15.25, but got nailed on Friday.
We still think $18-$20 is in the cards for this year.
Guidance has not been updated yet for the TURBO Booster. If this market didn’t stink so bad, helping to bail the shorts out, I think we would be North of $15 (and we were for a little while at least).
Now up 30% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.36, up $.49.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–75% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
Earnings coming out Thursday, 8/23 after the close.
Up 21% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $21.16, down $1.75 last week.
Like we have said in the past–this is a very volatile stock.
Over the long haul (years) we like this stock, but right now the play is a sale of the company due to Third Points involvement.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value.
If this reaches $30 in 2007, without a buy-out, we would sell.
Now up 10%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.28 (was $9.20, $8.32, $7.50, $7.63, $9.31)
Closed at $5.10, down $.25 for the week.
DWCH is now trading at 55% of our valuation. We have been buying more in the $5 to $5.40 range.
Now up 59%. BUY.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $3.35, down $.03 last week. It actually fell to the mid-$2 range last week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
No news.
Down 45%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, NEW Valuation $4.31 (was $4.01, $5.12, $5.88).
Closed at $1.43 up $.01 for the week.
Earnings last week. Not great. Lost $822,000 after a $558,000 inventory reserve. Excluding the inventory charge, our valuation moved up to $4.31. Including the the charge, it fell slightly to $3.96. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
Trading at 33% of our valuation.
Down 22%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), Valuation $23.22 (was $20.99, $20.52)
Closed at $12.06 down $.20 for the week.
For FY2008 they are projecting another 20% increase in sales and a tripling of operating income. They still have $2.95 a share in cash.
Down 7%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $17.85 (Was $18.18)
Down $.54 to $9.35 last week.
Stephen Roseman has still been buying a bit of BDAY. Another 7,300 shares at prices from $9.01 to $10.00 in late July and early August. Now has 619,000 shares or 7.8% of the company.
With the insider buying in the last couple of months, we like this stock alot.
Up 6%. BUY on dips below $9.00

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Up $.07 to $6.65 last week.
No news.
Penninsula Capital owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover
Down 4%. BUY

OB-abies (Bulletin Board Listed Stocks)

Nobody is liking our OB-abies lately (except maybe OPTIO). Just not their “time” yet. Patience.

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.66, up $.06 last week.
No news.
Now down 7%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up on investment), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.14, even last week.
No news.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
Down 39%. Hold.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.62, up $.08 last week.
Has cash of $.44 per share–27% of the market cap.
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
No news.
Up 30% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $.90, down $.05 last week.
AVSO announced a restructuring last month that is expected to save more than $2.5 million annually. They also narrowed their revenue guidance to between $50 and $51 million for 2007. They expect to lose money in Q4 (partly due to $500k in severance charges), but are projecting “significantly” better margins over recent results. They do not expect to lose money in FY 2008. We will wait to see this quarters results and any impact on our valuation.
Trading at 27% of our valuation.I bought some more on Friday at $.80. Just too CHEAP.
Now down 24%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price stayed the same last week at $.38. Closed at $.36.
This is still trading at only 29% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 41% based on the ASK price. HOLD.

Last week we went 4 up, 9 down and 1 even. Our biggest DOGS are: PARL, LINN.ob, BDR, AVSO.ob, ARIS.ob, ILOG and MEDW. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is -5.9%,+17.9% and +36.1% respectively. Since inception we are now 17 stocks up and 7 down (1 of which is down less than 10%).

We were down 5.9% this past week and are now up 17.9% so far in 2007. The DOW, NASDAQ and the S+P 500 were all down, with losses ranging from .6% (DOW) to 2.0% (NASDAQ) last week, and are all now up from 1.0% (S+P 500) to 5.8% (DOW) for the year.

We are now up more than triple the DOW and NASDAQ and 17 times the S+P 500 averages in 2007. The Russell 3000 and the Wilshire 5000 are both up about 1% for the year.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock (unless we double-up–then it is $20,000), less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Earnings on PDLI and DWCH last week.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.36 to $13.40 last week.
Up in a horrible week again!
Short Interest was 5.7 million at July 13th.
Got to be some short covering going on. It was nice to see SPNC trading ABOVE the ask price last week, instead of UNDER the bid price as it has been over the past few months.
Guidance has not been updated yet for the TURBO Booster. If this market didn’t stink so bad, helping to bail the shorts out, I think we would be North of $15.
SPNC presents at the Canaccord conference on August 7th, at 10AM, EST.
Now that they have something to talk about, SPNC is doing a pretty good job at getting the word out.
Now up 26% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $7.87, down $.12.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–86% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
Earnings coming out Thursday, 8/23 after the close.
Up 14% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $22.91, down $.90 last week.
Earning last week. They were good, in our opinion, but got swept away by mortgage worries in the overall markets.
Revenues were up 32%, Royalty revenues were up 48%, cash position is good.
What’s not to like?
Over the long haul (years) we like this stock, but right now the play is a sale of the company due to Third Points involvement.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
If this reaches $30 in 2007, without a buy-out, we would sell.
Now up 19%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), NEW Valuation $9.28 (was $9.20, $8.32, $7.50, $7.63, $9.31)
Closed at $5.35, down $.51 for the week.
As we posted earlier last week, DWCH earnings were good in our opinion and our valuation moved up slightly to $9.28. DWCH is now trading at 58% of our valuation. We have been buying more in the $5 to $5.40 range.
Now up 67%. BUY.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $3.38, down $.77 last week. Disgusting.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
No news.
Down 45%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.42 down $.09 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
Earnings due out 8/9 before the market opens.
Trading at 35% of our valuation.
Down 22%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), Valuation $23.22 (was $20.99, $20.52)
Closed at $12.26 up $.16 for the week.
For FY2008 they are projecting another 20% increase in sales and a tripling of operating income. They still have $2.95 a share in cash.
On Friday they announced they had a receivable from American Home Mortgage that was going to likely have to be written off. This will cost them $.03 a share. Probably take a hit next week, but this is immaterial to our valuation.
Down 5%. HOLD

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $17.85 (Was $18.18)
Up $.90 to $9.89 last week
BDAY got up to $10.70 last week before getting whacked for $.54 on Friday.
Looks like some good buying interest in a bad-bad market week. Maybe something is up?
With the insider buying in the last couple of months, we like this stock alot.
Up 12%. HOLD

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Down $.39 to $6.65 last week.
No news.
Penninsula Capital owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover
Down 5%. BUY

OB-abies (Bulletin Board Listed Stocks)

Nobody is liking our OB-abies lately (except maybe OPTIO). Just not their “time” yet. Patience.

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.60, up $.10 last week.
ARI announced an expanded relationship with Kawasaki last week. At least this news helped keep it from going down with the rest of the market.
Now down 10%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up on investment), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.14, down $.03 last week.
No news.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
Down 39%. Hold.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.54, down $.06 last week.
Got up to $1.75 before swooning with the rest of the stock market.
Has cash of $.44 per share–29% of the market cap.
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
No news.
Up 23% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $.95, down $.05 last week.
AVSO announced a restructuring 2 weeks ago that is expected to save more than $2.5 million annually. They also narrowed their revenue guidance to between $50 and $51 million for 2007. They expect to lose money in Q4 (partly due to $500k in severance charges), but are projecting “significantly” better margins over recent results. They do not expect to lose money in FY 2008. We will wait to see this quarters results and any impact on our valuation.
Trading at 29% of our valuation. Just too CHEAP.
Now down 20%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price stayed the same last week at $.38. Closed at $.38.
This is still trading at only 29% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 41% based on the ASK price. HOLD.

DWCH announced earnings this morning. They were good. Revenues were up 21% to almost $6.5 million and they made $.06 per share (partially taxed). Our valuation moved up a tad to $9.28 from $9.20. DWCH closed last Friday at $5.86. Markets are supposed to open down this morning, so we would watch this one closely. Sell target is $7.50 (cost–$3.21), but we may update this later.

Last week we went 5 up, 8 down and 1 even. Our biggest DOGS are: PARL, LINN.ob, BDR, AVSO.ob, ARIS.ob and ILOG. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is -2.2%,+23.8% and +42.9% respectively. Since inception we are now 18 stocks up and 6 down (1 of which is down less than 10%).

We were down 2.2% this past week and are now up 23.8% so far in 2007. The DOW, NASDAQ and the S+P 500 were all down, with losses ranging from 4.2% (DOW) to 4.9% (S+P 500) last week, and are all now up from 2.9% (S+P 500) to 6.4% (DOW) for the year.

We are now up more than triple the DOW and NASDAQ and 8 times the S+P 500 averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Earnings on SPNC, ILOG, and BDAY–and all pretty good. AVSO.ob news also.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.78 to $13.04 last week.
Up in a horrible week!
SPNC announced Q2 results last week. Revenues were up 27% from last year. Laser placements were 36 in Q2 versus 25 last year. Gross margin was 75% versus 74%. Pre-tax INCOME was $1,017,000 compared to $516,000 last year. This is a very good report, in our opinion. Yet short interest grew from 4.9 million to 5.7 million at July 13th and you can see the shorts playing their game almost every morning when they take the price down $.20 or $.30.
Guidance has not been updated yet for the TURBO Booster. If this market didn’t stink so bad, and the shorts realized that this is the wrong pony to be riding, we should have gone to $16 last week.
Now up 22% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $7.99, down $.29.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–76% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
Earnings coming out Thursday, 8/23 after the close.
Up 15% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $23.81, down $2.12 last week.
No significant news last week.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
Earnings out Wednesday 8/1 after the close.
If this reaches $30, without a buy-out, we would sell.
Now up 23%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.86, up $.01 for the week.
No significant news.
Earnings due out Monday 7/30 before the market opens. Hold on.
Hold for earnings.
Now up 83%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.15, down $.26 last week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
No news.
Down 32%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.51 down $.17 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 38% of our valuation.
Down 18%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), NEW Valuation $23.22 (was $20.99, $20.52)
Closed at $12.10 last week, down $.90.
Earnings last week. Q4 revenues up 35% to $46.3 million, earnngs up 40% to $.14 per share. For FY2008 they are projecting another 20% increase in sales and a tripling of operating income. Our valuation has moved up to $23.22, and they still have $2.95 a share in cash. We can’t find anything wrong with this stock other than they are based in France and the stock is thinly traded. We bought some more on Friday at $12.14.
Down 6%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, NEW Valuation $17.85 (Was $18.18)
Down $.07 to $8.99 last week
Earnings last week. Q4 sales were down 17% to $20.1 million from $24.2 million last year. Discontinuance of their “Storybook Heirloom” product line accounted for more than the revenue decline–$6.9 million. Net loss was reduced to $62,000 from $324,000 last year. Our valuation stayed essentially the same–$17.85 versus $18.18.
With the insider buying in the last couple of months, we like this stock alot.
Up 2%. BUY

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Up $.32 to $7.04 last week.
No news.
Penninsula Capital owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover
Up 1%. BUY

OB-abies (Bulletin Board Listed Stocks)

Nobody is liking our OB-abies lately (except maybe OPTIO). Just not their “time” yet. Patience.

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.50, up $.01 last week.
No news.
Now down 16%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up on investment), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.17, even last week.
No news.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
Down 26%. Hold.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.60, up $.20 last week.
Has cash of $.44 per share–28% of the market cap.
Up 14% last week, with some respectable volume. Maybe a deal is in the works?
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
No news.
Up 28% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.00, down $.10 last week.
AVSO announced a restructuring last week that is expected to save more than $2.5 million annually. They also narrowed their revenue guidance to between $50 and $51 million for 2007. They expect to lose money in Q4 (partly due to $500k in severance charges), but are projecting “significantly” better margins over recent results. They do not expect to lose money in FY 2008. We will wait to see this quarters results and any impact on our valuation.
Trading at 30% of our valuation. Just too CHEAP.
Now down 16%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price fell $.01 last week at $.38. Closed at $.38.
This is still trading at only 29% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 41% based on the ASK price. HOLD.

Last week we went 3 up and 11 down. Our biggest DOGS are: PARL, LINN.ob, ARIS.ob, BDR, AVSO.ob and MEDW. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is -3.8%,+26.0% and +45.4% respectively. Since inception we are now 18 stocks up and 6 down (3 of which are down less than 10%).

We were down 3.8% this past week and are now up 26.0% so far in 2007. The DOW, NASDAQ and the S+P 500 were all down with losses ranging from .4% (DOW) to 1.2% (S+P 500) last week, and are all now up from 8.2% (S+P 500) to 11.3% (NASDAQ) for the year.

We are still up more than double the DOW and NASDAQ and triple the S+P 500 averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Lots of news and scheduled earnings announced last week.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.01 to $12.26 last week.
We still think there is a lot of pent-up energy in this stock. But something has to break the short hold to make it move significantly. It could be Q2 earnings, or it could be new guidance–or it could be next year. Patience as always is needed.
Earnings next week, Wednesday before the market opens.
Short interest is almost 4.9 million shares.
Now up 15% so far. BUY.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.28, down $.32.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–76% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
Earnings coming out Thursday, 8/23 after the close.
Up 20% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $25.93, down $.29 last week.
Third Point continued their barrage on the PDL Board–get McDade out!
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
Earnings out Wednesday 8/1 after the close.
If this reaches $30, without a buy-out, we would sell.
Now up 34%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.85, up $.09 for the week.
Earnings due out Monday 7/30 before the market opens.
Hold for earnings.
Now up 82%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.41, down $.33 last week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
No news.
Down 28%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.68 down $.02 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 42% of our valuation.
Down 8%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), Valuation $20.99 (was $20.52)
Closed at $13.00 last week, down $.06.
Announced a deal with Bank of the West. At least they announced something!
Up 1%. HOLD

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $18.18
Down $.24 to $9.06 last week
With the insider buying in the last couple of months, we like this stock alot.
Earning due out on July 26th after the close.
Up 3%. HOLD

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Down $.22 to $6.72 last week.
Announced some consolidation and lay-offs on Friday. Maybe they are prettying it up for sale?
Penninsula Capital owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover
Down 4%. BUY

OB-abies (Bulletin Board Listed Stocks)

Nobody is liking our OB-abies lately. Just not their “time” yet. Patience.

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.49, down $.01 last week.
ARI announced a deal with Genie Industries last week. Good to hear that something is going on.
Now down 16%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up on investment), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.17, down $.03 last week.
Lion announced a new web-site last week. Hope someone buys it for a lot of money from them soon.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
Down 26%. Hold.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.40, up $.01 last week.
Has cash of $.44 per share–32% of the market cap.
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
No news.
Up 12% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.10, down $.04 last week.
AVSO plunged last week as low as $.81. As we suspected there WAS a seller out there of some volume. We may continue to nibble here at these prices.
Trading at 33% of our valuation. Just too CHEAP.
No news.
Now down 8%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price fell $.01 last week at $.39. Closed at $.39.
Had some VOIP partnership news last week. No impact on the stock.
This is still trading at only 31% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 44% based on the ASK price. HOLD.

Last week we went 8 up, 5 down and 1 even. Our biggest DOGS are: PARL, ARIS.ob, LINN.ob, BDR, AVSO.ob and MEDW. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is +3.6%,+29.8% and +49.7% respectively. Since inception we are now 18 stocks up and 6 down (2 of which are down less than 5%).

We were up 3.6% this past week and are now up 29.8% so far in 2007. The DOW, NASDAQ and the S+P 500 were all up with gains ranging from 1.4% (S&P 500) to 2.2% (DOW) last week, and are all now up from 9.5% (S+P 500) to 12.1% (NASDAQ) for the year.

We are now up more than double the DOW and NASDAQ and triple the S+P 500 averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

News on SPNC, PARL. Hopefully some news coming soon on PDLI!

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.22 to $12.25 last week.
SPNC got more good news last week with expanded labeling on the Turbo-Booster. Shorts continue to play here. Q2 results will hopefully be good. We think there is a lot of pent-up energy in this stock. But something has to break the short hold to make it move significantly. It could be Q2 earnings, or it could be new guidance–or it could be next year. Patience as always is needed.
Short interest is almost 4.9 million shares.
Now up 15% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.60, down $.05.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–70% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
No news
Up 24% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $26.22, up $2.75 last week.
It has been quiet for a couple of weeks here–until Friday. No news (yet) but the stock jumped $2.48. Q2 results are coming up also.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
If this reaches $30, without a buy-out, we would sell.
Now up 36%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.76, up $.21 for the week.
If this gets to $7 we would sell.
No news.
Now up 79%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.74, up $.24 last week.
They did manage to file their 10K last week and avoid SEC and listing issues.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
Down 23%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.70 down $.09 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 42% of our valuation.
Down 7%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), Valuation $20.99 (was $20.52)
Closed at $13.06 last week, up $.37.
No news.
Up 1%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $18.18
Up $.08 to $9.30 last week
With the insider buying in the last couple of months, we like this stock alot.
Earning due out on July 26th after the close.
Up 5%. HOLD

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Down $.18 to $6.94 last week.
Penninsula Capital owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover
No news.
Down .6%. BUY

OB-abies (Bulletin Board Listed Stocks)

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.50, down $.10 last week.
Now down 16%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up on investment), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.20, up $.03 last week.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
No news.
Down 13%. Hold.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.39, up $.04 last week.
Has cash of $.44 per share–32% of the market cap.
Optio announced some new business last week.
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
Up 11% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.14, down $.04 last week.
We bought more last week at $1.15-$1.16–however, there appears to be a good supply of stock for sale at these prices. We may continue to nibble here at these prices–there seems to be a seller out there willing to part with there shares.
Trading at 35% of our valuation.
No news.
Now down 4%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price was unchanged last week at $.40. Closed at $.37.
This is still trading at only 31% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 48% based on the ASK price. HOLD.

For some reason I cannot put a title on this weeks blog. Technical difficulties apparently.

Last week we went 9 up, 3 down and 2 even. Our biggest DOGS are: LINN.ob, PARL, ARIS.ob, BDR, ILOG and AVSO.ob. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is +1.5%,+26.1% and +45.6% respectively. Since inception we are now 18 stocks up and 6 down (3 of which are down less than 5%).

We were up 1.5% this past week and are now up 26.1% so far in 2007. The DOW, NASDAQ and the S+P 500 were all up with gains ranging from 1.5% (DOW) to 2.4% (NASDAQ) last week, and are all now up from 7.9% (S+P 500) to 10.4% (NASDAQ) for the year.

We are now up more than double the DOW and NASDAQ and triple the S+P 500 averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Holiday week. News on SPNC, and MEDW.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.51 to $12.03 last week.
Well the BIG announcement on the Turbo-Booster came last week, earlier than anyone expected. Price moved up, but not near what we hoped for. Shorts are STILL playing this one. Good example was Friday’s action where they took it down to $11.59 at the open on a few thousand shares, only to close at $12.03 by the end of the day. It seems that their hold on SPNC may be weakening, as it did not take that many shares traded on Friday to boost the stock to a gain for the day. New financial guidance is not due to be released until Q3 earnings in October. Q2 results will hopefully be good. We think there is a lot of pent-up energy in this stock. But something has to break the short hold to make it move significantly. It could be Q2, or it could be new guidance–or it could be next year. Patience as always is needed.
Short interest is almost 4.9 million shares.
Now up 13% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.65, up $.35.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–69% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
No news
Up 25% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $23.47, up $.17 last week.
It has been quiet for a couple of weeks here. Q2 results are coming up.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
If this reaches $30, without a buy-out, we would sell.
Now up 22%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.55, up $.10 for the week.
If this gets to $7 we would sell.
No news.
Now up 73%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.50, up $.06 last week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
Down 26%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.79 up $.18 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 45% of our valuation.
Down 2%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $12.92 (was $13.60 before double-up), Valuation $20.99 (was $20.52)
Closed at $12.69 last week, up $.39.
No news.
Down 2%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $18.18
Up $.18 to $9.22 last week
With the insider buying in the last couple of months, we like this stock alot.
Up 5%. HOLD

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Down $.08 to $7.12 last week.
CEO resigned last week. Not sure what this means yet.
Penninsula Capital now owns 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover.
Up 2%. BUY

OB-abies (Bulletin Board Listed Stocks)

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.60, down $.09 last week.
Now down 10%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.23 (was $.36 before double-up), Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.17, unchanged last week.
This one has cost us about 3% off our total 2007 performance so far.
Lion management has announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here.
Down 26%. BUY on the hopes of a deal here that cuts our losses.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.35, down $.09 last week.
Has cash of $.44 per share–33% of the market cap.
In late June, OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign has gone up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
Up 8% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.18, up $.03 last week.
Trading at 36% of our valuation.
No news.
Now down 1%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price was unchanged last week at $.40. Closed at $.38.
This is still trading at only 31% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 48% based on the ASK price. HOLD.

Last week we went 6 up and 7 down and 1 even. LINN.ob holds first place on our “biggest dog” list (by far) followed by PARL, BDR, ILOG, ARIS.ob and AVSO.ob. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is -.5%,+24.6% and +43.8% respectively. Since inception we are now 18 stocks up and 6 down (3 of which are down less than 10%).

We were down .5% this past week and are now up 24.6% so far in 2007. The DOW, NASDAQ and the S+P 500 were all up with gains ranging from 0% (S+P 500) to .6% (NASDAQ) last week, and are all now up from 6.0% (S+P 500) to 7.8% (NASDAQ) for the year.

We are now up more than triple all these averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

Interesting week. News on SPNC, PARL and OPTIO.ob.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $.29 to $11.52 last week.
Pacific Growth Equities issued a “BUY” on SPNC last week. Seems like all the investment firms are lining up to get on the Turbo-Booster bandwagon when it gets approved.
Short interest went up another 10% to almost 4.9 million shares.
We are just waiting for FDA approval. If the TURBO-Booster is approved (no reason to expect it will not be), this should be huge.
Now up 8% so far. HOLD.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.30, up $.11.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–78% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
No news
Up 20% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $23.30, down $.31.
Our gains continue to slip away on this one, and it makes no sense to us.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
If this reaches $30, without a buy-out, we would sell.
Now up 21%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.45, down $.41 for the week.
If this gets to $7 we would sell.
No news.
Now up 70%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.44, down $.11 last week.
Wild ride last week. PARL announced on Wednesday that they had signed a new licensing deal for a Jessica Simpson fragrance. The stock shot up to $5.44 and then slide all the way back and more by the end of the week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
Down 27%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.61 up $.05 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 40% of our valuation.
Down 12%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $13.60, Valuation $20.99 (was $20.52)
Closed at $12.30 last week, down $.14.
Double up time here. New buy price based on the double-up will be $12.92.
No news.
Down 9.6%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $18.18
Up $.40 to $9.04 last week
With the insider buying in the last couple of months, we like this stock alot.
Up 3%. HOLD

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Down $.25 to $7.20 last week.
Penninsula Capital filed a Form 4 last week. Bought another 11,300 shares week at $7.44. Now own 1.67 million shares or over 20% of MEDW. Not sure how they liguidate there stake profitably without a takeover.
Up 3%. BUY

OB-abies (Bulletin Board Listed Stocks)

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.69, unchanged last week.
Now down 5%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.36, Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.17, down $.02 last week.
This one has cost us about 3% off our total 2007 performance so far.
Well the militant shareholder group lost the proxy contest. But, apparently Lion management got the message and announced the formation of a “Strategic Review Committee” to explore the sale of the company or parts of the company. They said that they has received “preliminary” and “conditional” indications of interest from parties interested in acquiring “portions of the company”. Hopefully something will happen here. We would double up at this price. New price next week after adjusting for the double-up will be $.23.
Down 53%. BUY on the hopes of a deal here that cuts our losses.

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.44, up $.19 last week.
Has cash of $.44 per share–35% of the market cap.
Last week OPTIO announced they had hired an investment banker to help them review the “Strategic Alternatives” related to their Healthcare software division. In other words, a “for sale” sign just went up. Having been through their SEC filings, there appears to be no disclosure on the sales or operating results for this “division”, so there is no way for us to determine what this could mean from a valuation standpoint. Anyway–good news, we think, and the stock reacted favorably.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers, or they get a good deal on the Healthcare “division”.
Up 15% so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.15, down $.05 last week.
Trading at 35% of our valuation.
No news.
Now down 3%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price moved up $.05 last week at $.40. Closed at $.35.
This is still trading at only 31% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Up 48% based on the ASK price

Last week we went 4 up and 6 down and 4 even. LINN.ob holds first place on our “biggest dog” list (by far) followed by PARL, BDR, ILOG, ARIS.ob and BDAY. For the week, 2007 year-to-date, and since we started this Blog in January 2006, our model portfolio is +3.2%,+25.1% and +44.3% respectively. Since inception we are now 17 stocks up and 6 down (3 of which are down less than 10%) and 1 even.

We were up 3.2% this past week and are now up 25.1% so far in 2007. The DOW, NASDAQ and the S+P 500 were all down with losses ranging from 1.4% (NASDAQ) to 1.9% (NASDAQ + S+P 500) last week, and are all now up from 6.0% (S+P 500) to 7.4% (DOW) for the year. We are now up more than triple all these averages in 2007.

Since inception we have closed out the following positions:

2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007 DTLK +25% (2 weeks)

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

For the 10 stocks that we have closed out in 2006 and 2007 the average gain was 35%. We are tired of watching our stocks go up–and then down. So we are planning to take profits a bit sooner than in 2006. We have already closed out 6 positions in 2007 compared to 4 in all of 2006.

News on SPNC, AVSO.ob. 13D filed on MEDW also.

Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $10.65, Valuation $18-$20
Up $1.21 to $11.23 last week.
Nice jump in a bad market–finally. Piper Jaffray issued an “outperform” opinion on SPNC with a measley $13 price target–but it helped. Maybe they are just prepping for the TURBO-booster approval, and will then up their target price.
Short interest is 4.4 million shares. We are just waiting for FDA approval. If the TURBO-Booster is approved (no reason to expect it will not be), this should be huge.
Now up 5% so far. BUY.

QAD Inc. (QADI-Recommended 6/14/2006)
Buy price $6.93, Valuation $11.27 (was $15.92, $13.69, $13.73 and $11.86)
Closed at $8.19, down $.07.
Our valuation has fallen from $15.92 to $11.27, but if they can hit their guidance for the year, the valuation would be approximately $14.60–78% above the current price. But since they seem to have trouble hitting their numbers–we will hold for now.
No news
Up 18% so far. HOLD.

PDL BioPharma Inc. (PDLI-Recommended 5/21/2006)
Buy price $19.31, Valuation > $30
Closed at $23.61, down $1.07.
Our gains are slipping away on this one, and it makes no sense to us.
Activist investment firm Third Point LLC, owns 11.2 million shares or 9.7% of the company and has more than $200 million invested. They continue to exert pressure on PDL to improve shareholder value. This however, remains a very volatile stock.
If this reaches $30, without a buy-out, we would sell.
Now up 22%. HOLD.

DataWatch Corp. (DWCH-Recommended 2/12/2006)
Buy price $3.21 (averaged down from $3.66), Valuation $9.20 (was $8.32, $7.50, $7.63, $9.31)
Closed at $5.86, up $.62 for the week. DWCH did pop over $6 last week, but couldn’t hold there.
If this gets to $7 we would sell.
No news.
Now up 83%. HOLD.

Parlux Fragrances (PARL-Recommended 11/30/2006)
Buy price $6.12 (was $6.65 before double up), Valuation $8.63 (Was $13.77)
PARL closed at $4.55, unchanged last week.
New management needs to get to work on this one fast.
The new management has 2.2 million reasons to make this stock go up. Glenn Nussdorf paid $6 for his shares.
Down 26%. HOLD.

Blonder Tongue Laboratories (BDR-Recommended 3/4/2007)
Buy price $1.83, Valuation $4.01 (was $5.12, $5.88).
Closed at $1.56 down $.04 for the week.
Our valuation has dropped to $4.01. BDR is still cheap in our opinion, but they need a decent quarter to get this stock moving up.
No news.
Trading at 40% of our valuation.
Down 15%. HOLD

ILOG SA (ILOG-recommended 3/26/2007)
Buy price $13.60, Valuation $20.99 (was $20.52)
Closed at $12.44 last week, down $.18.
No news.
Down 9%. BUY

Celebrate Express (BDAY-recommended 4/17/2007
Buy Price $8.82, Valuation $18.18
Down $.40 to $8.51 last week
With the insider buying in the last couple of months, we like this stock alot.
Down 4%. BUY

Mediware (MEDW-Recommended 6/4/2007
Buy Price $6.98, Valuation $13.40
Up $.45 to $7.45 last week.
Penninsula Capital filed a 13D last week. Bought another 222,000 shares over the past few weeks at prices from $6.75 to $7.27. Now own 1.65 million shares or 20.4% of MEDW. They had previously filed 13G’s and have now converted to a 13D–maybe they are going to get more active in trying to get the value up here? Not sure how they liguidate there stake profitably without a takeover.
Up 7%. HOLD

OB-abies (Bulletin Board Listed Stocks)

ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.78 (was $2.06 before double up), Valuation $5.34 (was $5.03, $5.28, $5.28, $5.21)
Closed at $1.69, down $.05 last week.
Now down 5%. BUY. Still a Huge valuation gap here.

Lion Inc. (LINN.ob-Recommended 4/15/2006)
Buy price $.36, Valuation $.49 (was $.57, $.62, $.66 and before that $.79)
Closed at $.19, unchanged last week.
This one has cost us about 3% off our total 2007 performance so far.
One of the Lion co-founders and other shareholders started a proxy contest to get elected to the Board at the shareholders meeting last week (June 20). Obviously they are not happy with the company, or stock performance. With the cost cutting measures announced recently–maybe the proxy contest will liven the stock price up a bit. Would like to at least cut our losses on this one.
No news yet from the meeting or voting.
Down 47%. HOLD until we get some revenue growth and stop losing money (same story as last quarter(s)).

OPTIO Software Inc. (OPTO.ob-Recommended 3/22/2006)
Buy price $1.25, Valuation $2.28 (was $2.89, $2.89, $2.54 and 2.88)
Closed at $1.25, up $.10 last week.
Even with the lousy last quarter, there is still value here.
Has cash of $.44 per share–3%5 of the market cap.
Still hoping we will see north of $2.00 this year–but may not happen now unless next quarter rebounds with some decent numbers.
Dead even on this one so far. HOLD.

Avatech Solutions Inc. (AVSO.ob-Bought November 28, 2005)
Buy price $1.19,Valuation $3.25 (was $3.29 $2.69, $3.36, $3.81)
Stock closed at $1.20, unchanged last week.
AVSO.ob, announced a $200,000 sale last week and the stock did nothing.
Trading at 37% of our valuation.
No news.
Now up 1%. BUY.

CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask, Valuation $1.29 (Was $1.42, $1.28 $1.13, $1.05, $.82)
Ask price unchanged last week at $.37. Closed at $.35.
This is still trading at only 29% of our latest valuation, but until the VOIP business stops losing money, we are not buyers–yet.
Only 5,200 shares traded all of last week.
Up 37% based on the ASK price